ES2357620T3 - Nuevos betamiméticos de acción prolongada para el tratamiento de enfermedades de las vías respiratorias. - Google Patents

Nuevos betamiméticos de acción prolongada para el tratamiento de enfermedades de las vías respiratorias. Download PDF

Info

Publication number
ES2357620T3
ES2357620T3 ES06708235T ES06708235T ES2357620T3 ES 2357620 T3 ES2357620 T3 ES 2357620T3 ES 06708235 T ES06708235 T ES 06708235T ES 06708235 T ES06708235 T ES 06708235T ES 2357620 T3 ES2357620 T3 ES 2357620T3
Authority
ES
Spain
Prior art keywords
methyl
optionally
ethyl
formula
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06708235T
Other languages
English (en)
Spanish (es)
Inventor
Ingo Konetzki
Thierry Bouyssou
Christoph Hoenke
Andreas Schnapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2357620T3 publication Critical patent/ES2357620T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES06708235T 2005-02-19 2006-02-13 Nuevos betamiméticos de acción prolongada para el tratamiento de enfermedades de las vías respiratorias. Expired - Lifetime ES2357620T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005007654A DE102005007654A1 (de) 2005-02-19 2005-02-19 Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005007654 2005-02-19

Publications (1)

Publication Number Publication Date
ES2357620T3 true ES2357620T3 (es) 2011-04-28

Family

ID=36607505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06708235T Expired - Lifetime ES2357620T3 (es) 2005-02-19 2006-02-13 Nuevos betamiméticos de acción prolongada para el tratamiento de enfermedades de las vías respiratorias.

Country Status (10)

Country Link
US (1) US7423036B2 (enExample)
EP (1) EP1853596B1 (enExample)
JP (1) JP5140434B2 (enExample)
AR (1) AR053135A1 (enExample)
AT (1) ATE496913T1 (enExample)
CA (1) CA2598355A1 (enExample)
DE (2) DE102005007654A1 (enExample)
ES (1) ES2357620T3 (enExample)
TW (1) TW200640911A (enExample)
WO (1) WO2006087315A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
EP2057152A1 (de) * 2006-08-07 2009-05-13 Boehringer Ingelheim International GmbH Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
CA2660186A1 (en) * 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
GB0913342D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab Compounds - 801
WO2011048409A1 (en) 2009-10-20 2011-04-28 Astrazeneca Ab Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB201009801D0 (en) 2010-06-11 2010-07-21 Astrazeneca Ab Compounds 950
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
SK15382002A3 (sk) 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
BRPI0409198A (pt) * 2003-04-04 2006-05-02 Novartis Ag derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
EP1651221B1 (en) * 2003-07-28 2009-01-14 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising betamimetics and an anticholinergic agent
EP1654001A2 (en) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and a betamimetic
US7405232B2 (en) 2004-02-14 2008-07-29 Boehringer Ingelheim International Gmbh Long acting beta-2 agonists and their use as medicaments
DE502005010170D1 (de) * 2004-02-14 2010-10-14 Boehringer Ingelheim Pharma Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases

Also Published As

Publication number Publication date
ATE496913T1 (de) 2011-02-15
JP2008530176A (ja) 2008-08-07
CA2598355A1 (en) 2006-08-24
TW200640911A (en) 2006-12-01
EP1853596B1 (de) 2011-01-26
WO2006087315A1 (de) 2006-08-24
JP5140434B2 (ja) 2013-02-06
EP1853596A1 (de) 2007-11-14
DE102005007654A1 (de) 2006-08-24
DE502006008804D1 (de) 2011-03-10
US20060189607A1 (en) 2006-08-24
US7423036B2 (en) 2008-09-09
AR053135A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
ES2298993T3 (es) Nuevos agonistas beta-2-de efecto prolongado y su uso como medicamentos.
US7135500B2 (en) Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticals
US7056916B2 (en) Medicaments for the treatment of chronic obstructive pulmonary disease
ES2349470T3 (es) Nuevos beta-2-agonistas de acción de larga duración y su utilización como medicamentos.
ES2403184T3 (es) Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias
ES2362883T3 (es) Derivados de cicloalquilo sustituidos para el tratamiento de enfermedades respiratorias.
US20080132556A1 (en) 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases
AU2005286521B2 (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
JP2007537187A (ja) 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物
PL212238B1 (pl) Nowe związki betamimetyczne, ich zastosowanie, oraz preparat farmaceutyczny zawierający związek
ES2357620T3 (es) Nuevos betamiméticos de acción prolongada para el tratamiento de enfermedades de las vías respiratorias.
ES2370653T3 (es) Nuevos medicamentos para el tratamiento de enfermedades de las vías respiratorias.
KR20070022084A (ko) 베타 효능제의 흡입용 에어로졸 제형
US7405232B2 (en) Long acting beta-2 agonists and their use as medicaments
CA2660186A1 (en) Pharmaceutical combinations for the treatment of respiratory diseases
ES2355278T3 (es) Nuevos agonistas beta-2 de acción prolongada y su uso como medicamento.